CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 152 enrolled
Drug / intervention
Project X 26ml +2 moredrug
Likely dose
Project X 26mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03861780
NCT03861780Phase 3Completed
CompareCT.gov

Pilot Evaluation of Two Test Materials With a Positive Control When Used as a Patient Preoperative Skin Preparation

Professional Disposables International, Inc.·interventional·Posted Mar 4, 2019·Updated Oct 22, 2021

In Brief

A Phase 3 clinical trial evaluating Project X 26ml, Project X 5.1ml, and 1 other intervention for Bacteria Microflora Reduction. Completed, enrolled 152 participants across 1 site.

Detailed Summary

Comparative Study of Antimicrobial Effectiveness Evaluation of 26ml Project X, 5.1ml Project X and Prevantics Maxi Swabstick following ASTM E1173 - Standard Test Method for Evaluation of Preoperative, Precatheterization, or Preinjection Skin Preparations, ASTM International, West Conshohocken, Pennsylvania, 2015

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBacteria Microflora Reduction
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20192020202120222023202420252026
First PostedMar 4, 2019
Enrollment StartApr 2, 2019
Primary CompletionJun 6, 2019
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 7.3 years ago

Interventions

Project X 26mldrug

Application of antiseptic drug to the inguinal and abdomen areas of the subjects

Project X 5.1mldrug

Application of antiseptic drug to the inguinal and abdomen areas of the subjects

Prevantics Maxi Swabstickdrug

Application of antiseptic drug to the inguinal and abdomen areas of the subjects